Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Buy
63
ULTA Quote, Financials, Valuation and Earnings
Last price:
$471.18
Seasonality move
:
0.7%
Day range:
$466.83 - $491.98
52-week range:
$309.01 - $491.98
Dividend yield:
0%
P/E ratio:
18.42x
P/S ratio:
1.93x
P/B ratio:
8.72x
Volume:
4.6M
Avg. volume:
854.6K
1-year change:
22.27%
Market cap:
$21.2B
Revenue:
$11.3B
EPS (TTM):
$25.60
Analysts' Opinion
-
Consensus RatingUlta Beauty has received a consensus rating of Hold. The company's average rating is a Hold based on 9 Buy ratings, 13 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $474.67, Ulta Beauty has an estimated upside of 0.68% from its current price of $471.46.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $350.00 representing 25.76% downside risk from its current price of $471.46.
Fair Value
-
According to the consensus of 23 analysts, Ulta Beauty has 0.68% upside to fair value with a price target of $474.67 per share.
ULTA vs. S&P 500
-
Over the past 5 trading days, Ulta Beauty has overperformed the S&P 500 by 12.76% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Ulta Beauty does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ulta Beauty has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Ulta Beauty reported revenues of $2.8B.
Earnings Growth
-
Ulta Beauty has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Ulta Beauty reported earnings per share of $6.70.
Enterprise value:
20.7B
EV / Invested capital:
8.53x
Price / LTM sales:
1.93x
EV / EBIT:
13.14x
EV / Revenue:
1.82x
PEG ratio (5yr expected):
9.12x
EV / Free cash flow:
20.00x
Price / Operating cash flow:
21.23x
Enterprise value / EBITDA:
11.19x
Gross Profit (TTM):
$4.4B
Return On Assets:
20.35%
Net Income Margin (TTM):
10.45%
Return On Equity:
50.14%
Return On Invested Capital:
49.32%
Operating Margin:
14.17%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Income Statement | ||||||
| Revenue | $10.5B | $11.3B | $11.4B | $2.7B | $2.8B | |
| Gross Profit | $4.2B | $4.4B | $4.4B | $1.1B | $1.1B | |
| Operating Income | $1.7B | $1.6B | $1.6B | $403.9M | $403.6M | |
| EBITDA | $1.9B | $1.9B | $1.9B | $468.6M | $475.6M | |
| Diluted EPS | $24.60 | $25.64 | $25.60 | $6.47 | $6.70 | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.6B | $2.5B | $2.7B | $2.8B | $2.9B | |
| Total Assets | $5.1B | $5B | $5.4B | $5.6B | $6B | |
| Current Liabilities | $1.5B | $1.6B | $1.6B | $1.6B | $1.8B | |
| Total Liabilities | $3.2B | $3.3B | $3.4B | $3.3B | $3.6B | |
| Total Equity | $1.8B | $1.7B | $2B | $2.3B | $2.4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.4B | $1.3B | $1.4B | $159.3M | $220M | |
| Cash From Investing | -$352.8M | -$424.9M | -$375.9M | -$93.6M | -$86.4M | |
| Cash From Financing | -$1B | -$1B | -$1.1B | -$307.8M | -$382.2M | |
| Free Cash Flow | $1B | $914.2M | $1B | $68.3M | $141M | |
ULTA
Sector
Market Cap
$21.2B
$410.3M
Price % of 52-Week High
95.83%
71.02%
Dividend Yield
0%
0%
Shareholder Yield
6.14%
3.91%
1-Year Price Total Return
22.27%
-13.51%
Beta (5-Year)
1.059
0.782
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$421.02
200-day SMA
Buy
Level
$383.46
Bollinger Bands (100)
Buy
Level
355.64 - 413.58
Chaikin Money Flow
Buy
Level
44.4M
20-day SMA
Buy
Level
$409.46
Relative Strength Index (RSI14)
Buy
Level
78.21
ADX Line
Buy
Level
28.58
Williams %R
Neutral
Level
-22.9325
50-day SMA
Buy
Level
$384.17
MACD (12, 26)
Buy
Level
14.40
25-day Aroon Oscillator
Buy
Level
92
On Balance Volume
Neutral
Level
79.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.6077)
Buy
CA Score
(Annual)
Level (1.083)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.2138)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
With more than 1,400 freestanding stores and 600 Target shop-in-shops, Ulta Beauty is the largest specialized beauty retailer in the US. The firm offers cosmetics (39% of 2024 sales), fragrances (13%), skin care (23%), and hair care products (19%). It also offers salon services, including hair, makeup, skin, and brow, that account for about 4% of its revenue and drive traffic. In addition, it collects royalties through its Target partnership and credit card revenue. Most standalone Ulta stores are approximately 10,000 square feet and are in suburban strip centers. The firm will soon open franchised stores in Mexico and has formed a joint venture to expand into the Middle East. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Stock Forecast FAQ
In the current month, ULTA has received 9 Buy ratings 13 Hold ratings, and 1 Sell ratings. The ULTA average analyst price target in the past 3 months is $474.67.
-
Where Will Ulta Beauty Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ulta Beauty share price will rise to $474.67 per share over the next 12 months.
-
What Do Analysts Say About Ulta Beauty?
Analysts are divided on their view about Ulta Beauty share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ulta Beauty is a Sell and believe this share price will drop from its current level to $350.00.
-
What Is Ulta Beauty's Price Target?
The price target for Ulta Beauty over the next 1-year time period is forecast to be $474.67 according to 23 Wall Street analysts, 9 of them rate the stock a Buy, 1 rates the stock a Sell, and 13 analysts rate the stock a Hold.
-
Is ULTA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ulta Beauty is a Hold. 13 of 23 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ULTA?
You can purchase shares of Ulta Beauty via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ulta Beauty shares.
-
What Is The Ulta Beauty Share Price Today?
Ulta Beauty was last trading at $471.18 per share. This represents the most recent stock quote for Ulta Beauty. Yesterday, Ulta Beauty closed at $471.46 per share.
-
How To Buy Ulta Beauty Stock Online?
In order to purchase Ulta Beauty stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
